Verastem (VSTM)

[realfast95]

You have me confused with someone else. I'm saying the stock is only good for trading. The company will never be profitable and isn't a long term home run.

There was a convincing report floating around in Stocktwits, (won't be able to find it now). That indicated that the doctors won't prescribe this product (in quantity)

I had the same problem with $EGLT. They got FDA approvals, but the insurance companies and the doctors would not prescribe them in quantity that would make the company profitable. The stock reached $8-$9 on approval. Now it's $.16 after a few quarters of low sales and high costs of staff trying to sell it.

Biotech traders are pro's. They know when to run it and then short it. Selling calls etc. The same thing will happen here.
Last nights news was a good one. It will have caught the shorts by surprise. But they will take care of it during the day.

The analysts just want to be in good favor with the company, so they can win more secondary stock offerings.